Infectious Disease Doctors in New London, CT Accepting Medicare
4 Infectious Disease doctors found. Showing 1 - 4
 Dr. Alin Bortan, MD Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 365 Montauk Avenue, New London, CT 06320 Phone: 860-444-3735 Fax: 860-443-1817 |
Joseph J Gadbaw, M.D. Internal Medicine - Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 365 Montauk Ave, New London, CT 06320 Phone: 860-442-0711 Fax: 860-443-1817 |
Martin Ucanda, MD Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 365 Montauk Ave, New London, CT 06320 Phone: 860-271-4364 |
Michael E Dobson, M.D. Internal Medicine - Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 365 Montauk Ave, New London, CT 06320 Phone: 860-442-0711 Fax: 860-443-1817 |
News Archive
State Senate passes legislation to protect, return wandering elders with Alzheimer's disease
The Alzheimer's Association announced that passage of legislation today by the State Senate to establish a Silver Alert program will help hundreds of thousands in Massachusetts. The legislation, passed unanimously last week in the House, calls for program similar to Amber Alert with distinct differences. Silver Alert will be activated when an adult with Alzheimer's or other type of dementia wanders.
St. Jude's EnligHTN renal denervation system safe and effective in treating resistant hypertension
St. Jude Medical, Inc., a global medical device company, today announced that interim data demonstrated the company's EnligHTN renal denervation system is safe and effective for the treatment of resistant hypertension.
DuPont receives EC approval to acquire all Danisco shares for DKK 665
The European Commission has approved, under the European Union Merger Regulation, the tender offer by DuPont Denmark Holding ApS to acquire all of the outstanding shares of Danisco at a price of DKK 665 in cash per share.
New gene called DEAR1 may be a breast cancer diagnostic marker
In a research article published in this week's PLoS Medicine, Ann Killary (from the University of Texas M. D. Anderson Cancer Center) and colleagues describe a new gene called DEAR1 that is genetically altered by mutation and deletion in breast tumors, and that may provide a new breast cancer prognostic marker.
› Verified 3 days ago
Internal Medicine
Emergency Medicine
Family Medicine
Psychiatry & Neurology
Anesthesiology
Radiology
Pediatrics
Obstetrics & Gynecology
Surgery
Pathology